Product Management Service (PMS) – Frequently Asked Questions (FAQs)
Product Management Service (PMS) – Frequently Asked Questions (FAQs)
Product Management Service (PMS) – Frequently Asked Questions (FAQs)
3Rs Working Party (3RsWP) stakeholder meeting - Public session on the 2026-2028 work plan, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 31 March 2026, 09:30 (CEST) to 31 March 2026, 10:30 (CEST)
Opinions and letters of support on the qualification of novel methodologies for medicine development
Annex 4 - Big MS Data (BMSD) feasibility study
Annex 1 - Qualification opinion briefing book for the Big MS Data network registries on Post Authorization Safety Studies
Annex 2 - Observational long-term safety surveillance registry studies in the Big MS Data (BMSD) network
Draft qualification opinion for the Big Multiple Sclerosis Data (BMSD) network
Annex 5 - Initial Qualification Procedure - List of Issues - Big MS Data Network (BMSD) and incorporated multiple sclerosis (MS)
Process for the electronic submission of medicinal product information - Chapter 3
Product Management Services (PMS) - Implementation of International Organization for Standardization (ISO) standards for the identification of medicinal products (IDMP) in Europe - Chapter 2 - tracked changes